B
Bailard Portfolio holdings
AUM
$4.29B
1-Year Return
18.39%
This Quarter Return
+8.57%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$3.62B
AUM Growth
+$248M
(+7.3%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
28.3%
Holding
840
New
137
Increased
216
Reduced
252
Closed
109
Top Buys
| 1 |
iShares Russell 2000 Value ETF
IWN
|
$73M |
| 2 |
iShares California Muni Bond ETF
CMF
|
$29.7M |
| 3 |
TSMC
TSM
|
$12.9M |
| 4 |
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
|
$12.4M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$7.8M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$69.1M |
| 2 |
SPDR Nuveen ICE Municipal Bond ETF
TFI
|
$29.8M |
| 3 |
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
|
$8.07M |
| 4 |
CVS Health
CVS
|
$7.37M |
| 5 |
IBTE
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
|
$7.34M |
Sector Composition
| 1 | Technology | 21.1% |
| 2 | Healthcare | 8.25% |
| 3 | Financials | 6.95% |
| 4 | Communication Services | 4.78% |
| 5 | Consumer Discretionary | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
701
DELISTED
Inozyme Pharma
INZY
| $186K | 0.01% |
+24,300
| New | +$186K |
|
702
Liquidity Services
LQDT
$830M
| $186K | 0.01% |
+10,000
| New | +$186K |
|
703
Viatris
VTRS
$12.2B
| $185K | 0.01% |
15,530
+210
| +1% | +$2.51K |
|
|
PETQ
704
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $183K | 0.01% |
+10,000
| New | +$183K |
|
705
Tenaya Therapeutics
TNYA
$217M
| $172K | ﹤0.01% |
32,900
| – | – |
|
706
GoodRx Holdings
GDRX
$1.41B
| $165K | ﹤0.01% |
+23,200
| New | +$165K |
|
707
Caesarstone
CSTE
$48.7M
| $162K | ﹤0.01% |
+39,555
| New | +$162K |
|
708
Alight
ALIT
$1.98B
| $162K | ﹤0.01% |
16,400
-14,600
| -47% | -$144K |
|
709
Community Health Systems
CYH
$406M
| $159K | ﹤0.01% |
+45,400
| New | +$159K |
|
710
Laureate Education
LAUR
$4.07B
| $152K | ﹤0.01% |
10,400
| – | – |
|
711
Future Fuel
FF
$172M
| $151K | ﹤0.01% |
+18,800
| New | +$151K |
|
712
SiriusPoint
SPNT
$2.18B
| $150K | ﹤0.01% |
+11,800
| New | +$150K |
|
713
Hamilton Insurance Group
HG
$2.42B
| $145K | ﹤0.01% |
+10,400
| New | +$145K |
|
714
Trevi Therapeutics
TRVI
$861M
| $141K | ﹤0.01% |
+40,900
| New | +$141K |
|
715
LXP Industrial Trust
LXP
$2.68B
| $140K | ﹤0.01% |
15,546
-20,400
| -57% | -$184K |
|
716
Voyager Therapeutics
VYGR
$232M
| $128K | ﹤0.01% |
+13,700
| New | +$128K |
|
717
IonQ
IONQ
$12.5B
| $126K | ﹤0.01% |
12,600
| – | – |
|
718
SIGA Technologies
SIGA
$600M
| $122K | ﹤0.01% |
+14,300
| New | +$122K |
|
719
Anywhere Real Estate
HOUS
$717M
| $118K | ﹤0.01% |
+19,100
| New | +$118K |
|
720
Organogenesis Holdings
ORGO
$633M
| $115K | ﹤0.01% |
40,400
+4,500
| +13% | +$12.8K |
|
|
SGMA
721
DELISTED
Sigmatron International
SGMA
| $113K | ﹤0.01% |
31,154
+9,879
| +46% | +$35.9K |
|
722
Athira Pharma
ATHA
$15.5M
| $111K | ﹤0.01% |
+40,473
| New | +$111K |
|
723
Lifetime Brands
LCUT
$96.1M
| $110K | ﹤0.01% |
+10,500
| New | +$110K |
|
724
Spero Therapeutics
SPRO
$121M
| $105K | ﹤0.01% |
+60,900
| New | +$105K |
|
|
NHS
725
Neuberger Berman High Yield Strategies Fund
NHS
$229M
| $87.4K | ﹤0.01% |
10,839
| – | – |
|